STOCK TITAN

CSW INDUSTRIALS (CSW) CEO sells 1,500 shares under 10b5-1 plan

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

CSW INDUSTRIALS, INC. Chairman, President & CEO Joseph B. Armes sold 1,500 shares of common stock in an open-market transaction at a weighted average price of $270.11 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan.

Following the sale, Armes directly holds 59,526 common shares and indirectly holds 3,219 shares through an ESOP. He also retains multiple performance-rights awards and 19,685 restricted stock units that can settle in cash or common stock based on future vesting conditions.

Positive

  • None.

Negative

  • None.
Insider Armes Joseph B
Role Chairman, President & CEO
Sold 1,500 shs ($405K)
Type Security Shares Price Value
Sale Common Stock 1,500 $270.11 $405K
holding Performance Rights -- -- --
holding Performance Rights -- -- --
holding Performance Rights -- -- --
holding Performance Rights -- -- --
holding Restricted Stock Units -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 59,526 shares (Direct); Performance Rights — 8,004 shares (Direct); Restricted Stock Units — 19,685 shares (Direct); Common Stock — 3,219 shares (Indirect, by ESOP)
Footnotes (1)
  1. The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles ending on each of March 31, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Armes Joseph B

(Last)(First)(Middle)
5420 LYNDON B JOHNSON FWY
STE. 500

(Street)
DALLAS TEXAS 75240-1007

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CSW INDUSTRIALS, INC. [ CSW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chairman, President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/23/2026S(1)1,500D$270.11(2)59,526D
Common Stock3,219Iby ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Rights(3) (3) (3)Common Stock8,0048,004D
Performance Rights(4) (4) (4)Common Stock8,2368,236D
Performance Rights(5) (5) (5)Common Stock12,42212,422D
Performance Rights(6) (6) (6)Common Stock18,37218,372D
Restricted Stock Units(7) (7) (7)Common Stock19,68519,685D
Explanation of Responses:
1. The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
4. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
5. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
6. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles ending on each of March 31, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
7. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Remarks:
/s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes03/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CSW (CSW) report for Joseph B. Armes?

CSW INDUSTRIALS reported that Chairman, President & CEO Joseph B. Armes sold 1,500 common shares in an open-market transaction. The weighted average sale price was $270.11 per share, with trades occurring between $270.00 and $270.50.

Was the CSW (CSW) insider sale by Joseph B. Armes pre-planned?

Yes. The sale by Joseph B. Armes was carried out under a Rule 10b5-1 trading plan. This plan was established on August 12, 2025, indicating the transaction followed a pre-arranged schedule rather than being made on a discretionary basis.

How many CSW (CSW) shares does Joseph B. Armes hold after this Form 4?

After the reported sale, Joseph B. Armes directly holds 59,526 shares of CSW INDUSTRIALS common stock. He also indirectly holds 3,219 additional shares through an ESOP, providing further equity exposure beyond his direct ownership position.

What equity awards linked to CSW (CSW) common stock does Joseph B. Armes retain?

Joseph B. Armes holds several performance-rights awards and 19,685 restricted stock units tied to CSW INDUSTRIALS common stock. These awards vest over multi-year performance or service periods and may be settled in either cash or shares at the company’s discretion.

How are CSW (CSW) performance rights for Joseph B. Armes structured?

Each performance right represents a contingent right to one CSW INDUSTRIALS share. Vesting ranges from 0% to 200% over three-year cycles, based on relative total shareholder return versus the Russell 2000 Index, with settlement possible in cash or common stock.

What conditions affect vesting of CSW (CSW) restricted stock units for Joseph B. Armes?

Each restricted stock unit represents a contingent right to one CSW INDUSTRIALS share. 40% of the units vest upon successful recruitment and hiring of a successor CEO, and the remaining 60% vest upon that successor CEO’s first employment anniversary.